z-logo
open-access-imgOpen Access
Roscovitine, a CDK5 Inhibitor, Alleviates Sevoflurane-Induced Cognitive Dysfunction via Regulation Tau/GSK3β and ERK/PPARγ/CREB Signaling
Author(s) -
Jianhui Liu,
Junjun Yang,
Yinhua Xu,
Gang Guo,
Li Cai,
Heng Wu,
Yanhong Zhao,
Xiaoqing Zhang
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000485008
Subject(s) - creb , sevoflurane , morris water navigation task , cyclin dependent kinase 5 , mapk/erk pathway , medicine , neuroprotection , gsk 3 , hippocampus , cyclic amp response element binding protein , protein kinase a , endocrinology , pharmacology , kinase , neuroscience , biology , microbiology and biotechnology , mitogen activated protein kinase kinase , transcription factor , biochemistry , gene
Multiple exposures to anesthesia in children may increase the risk of developing cognitive impairment. Sevoflurane is an anesthetic that is commonly used in children during surgery. Cyclin-dependent kinase (CDK) 5 is involved in the regulation of sevoflurane-induced cognitive dysfunction, but the mechanistic details remain unclear. The present study evaluated the mechanism by which CDK5 mediates sevoflurane-induced cognitive dysfunction in mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom